FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.4.11  |  FHIR Version n/a  User: [n/a]

Resource ValueSet/FHIR Server from package us.nlm.vsac#0.21.0 (141 ms)

Package us.nlm.vsac
Type ValueSet
Id Id
FHIR Version R4
Source http://fhir.org/packages/us.nlm.vsac/https://vsac.nlm.nih.gov/valueset/2.16.840.1.113883.3.464.1003.196.11.1222/expansion
Url http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.464.1003.196.11.1222
Version 20210914
Status active
Date 2021-09-14T01:01:12-04:00
Name InactivatedPolioVaccineIPV
Title Inactivated Polio Vaccine (IPV)
Experimental False
Realm us
Authority hl7
Purpose (Clinical Focus: The purpose of this value set is to represent concepts for immunizations with inactivated polio vaccines (IPV).),(Data Element Scope: This value set may use a model element related to Immunization.),(Inclusion Criteria: Includes concepts that represent an inactivated polio vaccine (IPV).),(Exclusion Criteria: No exclusions.)

Resources that use this resource

ValueSet
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.464.1003.196.12.1219 Inactivated Polio Vaccine (IPV)

Resources that this resource uses

CodeSystem
http://hl7.org/fhir/sid/cvx Vaccine Administered Code Set (CVX)
http://hl7.org/fhir/sid/cvx Vaccine Administered Code Set (CVX)
http://hl7.org/fhir/sid/cvx CVX codes used in this IG


Source

{
  "resourceType" : "ValueSet",
  "id" : "2.16.840.1.113883.3.464.1003.196.11.1222",
  "meta" : {
    "versionId" : "25",
    "lastUpdated" : "2023-12-21T17:43:03.000-05:00",
    "profile" : [
      "http://hl7.org/fhir/StructureDefinition/shareablevalueset",
      "http://hl7.org/fhir/us/cqfmeasures/StructureDefinition/computable-valueset-cqfm",
      "http://hl7.org/fhir/us/cqfmeasures/StructureDefinition/publishable-valueset-cqfm"
    ]
  },
  "extension" : [
    {
      "url" : "http://hl7.org/fhir/StructureDefinition/valueset-author",
      "valueContactDetail" : {
        "name" : "NCQA PHEMUR Author"
      }
    },
    {
      "url" : "http://hl7.org/fhir/StructureDefinition/resource-lastReviewDate",
      "valueDate" : "2024-02-14"
    },
    {
      "url" : "http://hl7.org/fhir/StructureDefinition/valueset-effectiveDate",
      "valueDate" : "2021-09-14"
    }
  ],
  "url" : "http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.464.1003.196.11.1222",
  "identifier" : [
    {
      "system" : "urn:ietf:rfc:3986",
      "value" : "urn:oid:2.16.840.1.113883.3.464.1003.196.11.1222"
    }
  ],
  "version" : "20210914",
  "name" : "InactivatedPolioVaccineIPV",
  "title" : "Inactivated Polio Vaccine (IPV)",
  "status" : "active",
  "experimental" : false,
  "date" : "2021-09-14T01:01:12-04:00",
  "publisher" : "NCQA PHEMUR",
  "jurisdiction" : [
    {
      "coding" : [
        {
          "system" : "urn:iso:std:iso:3166",
          "code" : "US"
        }
      ]
    }
  ],
  "purpose" : "(Clinical Focus: The purpose of this value set is to represent concepts for immunizations with inactivated polio vaccines (IPV).),(Data Element Scope: This value set may use a model element related to Immunization.),(Inclusion Criteria: Includes concepts that represent an inactivated polio vaccine (IPV).),(Exclusion Criteria: No exclusions.)",
  "compose" : {
    "include" : [
      {
        "system" : "http://hl7.org/fhir/sid/cvx",
        "concept" : [
          {
            "code" : "10",
            "display" : "poliovirus vaccine, inactivated"
          },
          {
            "code" : "110",
            "display" : "DTaP-hepatitis B and poliovirus vaccine"
          },
          {
            "code" : "120",
            "display" : "diphtheria, tetanus toxoids and acellular pertussis vaccine, Haemophilus influenzae type b conjugate, and poliovirus vaccine, inactivated (DTaP-Hib-IPV)"
          },
          {
            "code" : "146",
            "display" : "Diphtheria and Tetanus Toxoids and Acellular Pertussis Adsorbed, Inactivated Poliovirus, Haemophilus b Conjugate (Meningococcal Protein Conjugate), and Hepatitis B (Recombinant) Vaccine."
          },
          {
            "code" : "89",
            "display" : "poliovirus vaccine, unspecified formulation"
          }
        ]
      }
    ]
  },
  "expansion" : {
    "identifier" : "urn:uuid:5ddeea80-6959-4296-9a1a-fc074deda6de",
    "timestamp" : "2024-12-10T10:49:17-05:00",
    "total" : 5,
    "contains" : [
      {
        "system" : "http://hl7.org/fhir/sid/cvx",
        "version" : "20240905",
        "code" : "10",
        "display" : "poliovirus vaccine, inactivated"
      },
      {
        "system" : "http://hl7.org/fhir/sid/cvx",
        "version" : "20240905",
        "code" : "110",
        "display" : "DTaP-hepatitis B and poliovirus vaccine"
      },
      {
        "system" : "http://hl7.org/fhir/sid/cvx",
        "version" : "20240905",
        "code" : "120",
        "display" : "diphtheria, tetanus toxoids and acellular pertussis vaccine, Haemophilus influenzae type b conjugate, and poliovirus vaccine, inactivated (DTaP-Hib-IPV)"
      },
      {
        "system" : "http://hl7.org/fhir/sid/cvx",
        "version" : "20240905",
        "code" : "146",
        "display" : "Diphtheria and Tetanus Toxoids and Acellular Pertussis Adsorbed, Inactivated Poliovirus, Haemophilus b Conjugate (Meningococcal Protein Conjugate), and Hepatitis B (Recombinant) Vaccine."
      },
      {
        "system" : "http://hl7.org/fhir/sid/cvx",
        "version" : "20240905",
        "code" : "89",
        "display" : "poliovirus vaccine, unspecified formulation"
      }
    ]
  },
  "text" : {
  }
}

XIG built as of ??metadata-date??. Found ??metadata-resources?? resources in ??metadata-packages?? packages.